Nasze publikacje:
Nasze publikacje:

Development and Characterization of a Camelid Single Domain Antibody–Urease Conjugate That Targets Vascular Endothelial Growth Factor Receptor 2

 

imageBaomin Tian1, imageWah Yau Wong1, imageMarni D. Uger1, imagePawel Wisniewski2 and imageHeman Chao1*
  • 1Helix BioPharma Corp., Toronto, ON, Canada
  • 2Helix ImmunoOncology, Warsaw, Poland

 

ORIGINAL RESEARCH ARTICLE

Front. Immunol., 21 August 2017 | https://doi.org/10.3389/fimmu.2017.00956
Download attachments.